Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.verified

ALXN

Price:

$182.5

Market Cap:

$0

Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS (eculizumab), a monoclonal antibody for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. In addition, the company is developing ALXN12...[Read more]

Industry

Biotechnology

IPO Date

1996-02-01

Stock Exchange

NASDAQ

Ticker

ALXN

The Enterprise Value as of December 2025 (TTM) for Alexion Pharmaceuticals, Inc. (ALXN) is -402500000.00

According to Alexion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -402500000.00. This represents a change of -101.38% compared to the average of 29.09B of the last 4 quarters.

Alexion Pharmaceuticals, Inc. (ALXN) Historical Enterprise Value (quarterly & annually)

How has ALXN Enterprise Value performed in the past?

The mean historical Enterprise Value of Alexion Pharmaceuticals, Inc. over the last ten years is 27.39B. The current -402500000.00 Enterprise Value has changed -246.93% with respect to the historical average. Over the past ten years (40 quarters), ALXN's Enterprise Value was at its highest in in the December 2015 quarter at 45.45B. The Enterprise Value was at its lowest in in the June 2011 quarter at 8.26B.

Quarterly (TTM)
Annual

Average

27.39B

Median

27.32B

Minimum

12.56B

Maximum

43.16B

Alexion Pharmaceuticals, Inc. (ALXN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alexion Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 81.28%

Maximum Annual Enterprise Value = 43.16B

Minimum Annual Increase = -31.66%

Minimum Annual Enterprise Value = 12.56B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202033.83B40.21%
201924.13B3.39%
201823.34B-19.75%
201729.08B-1.41%
201629.50B-31.66%
201543.16B20.66%
201435.77B39.91%
201325.57B50.27%
201217.01B35.45%
201112.56B81.28%

Alexion Pharmaceuticals, Inc. (ALXN) Average Enterprise Value

How has ALXN Enterprise Value performed in the past?

The current Enterprise Value of Alexion Pharmaceuticals, Inc. (ALXN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

27.10B

5-year avg

27.97B

10-year avg

27.39B

Alexion Pharmaceuticals, Inc. (ALXN) Enterprise Value vs. Peers

How is ALXN’s Enterprise Value compared to its peers?

Alexion Pharmaceuticals, Inc.’s Enterprise Value is less than Seagen Inc. (42.88B), less than Ambrx Biopharma Inc. (1.73B), less than Odonate Therapeutics, Inc. (24.10B), less than La Jolla Pharmaceutical Company (-44025000.00), less than Niagen Bioscience Inc (464.10M), less than Roivant Sciences Ltd. (14.23B), less than Takara Bio Inc. (82.51B), less than Arena Pharmaceuticals, Inc. (-183361000.00), less than EQRx, Inc. (650.25M), less than POINT Biopharma Global Inc. (1.05B),

Build a custom stock screener for Alexion Pharmaceuticals, Inc. (ALXN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alexion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alexion Pharmaceuticals, Inc. (ALXN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alexion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Alexion Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Alexion Pharmaceuticals, Inc. (ALXN)?

What is the 3-year average Enterprise Value for Alexion Pharmaceuticals, Inc. (ALXN)?

What is the 5-year average Enterprise Value for Alexion Pharmaceuticals, Inc. (ALXN)?

How does the current Enterprise Value for Alexion Pharmaceuticals, Inc. (ALXN) compare to its historical average?